Zecotek Photonics Inc.
Zecotek Photonics Inc. (ZMSPF) Stock Competitors & Peer Comparison
See (ZMSPF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ZMSPF | $0.00 | +900.00% | 12.3M | N/A | N/A | N/A |
| SMMNY | $26.71 | -0.73% | 119.9B | 24.30 | $1.10 | +1.95% |
| SEMHF | $54.50 | +1.21% | 61.7B | 25.13 | $2.19 | +1.80% |
| RYLPF | $26.50 | -5.36% | 25.2B | 147.19 | $0.18 | +3.59% |
| SONVF | $298.00 | +9.61% | 17.8B | 26.80 | $11.12 | +1.76% |
| SONVY | $54.94 | +2.01% | 16.4B | 24.77 | $2.22 | +1.15% |
| CHEOY | $101.24 | +0.45% | 13.2B | 55.02 | $1.84 | +1.38% |
| SNNUF | $15.00 | +0.40% | 13.1B | 31.91 | $0.47 | +2.50% |
| CHEOF | $182.00 | -10.21% | 11.9B | 49.86 | $3.65 | +1.52% |
| WILYY | $21.51 | +6.54% | 9.2B | 21.09 | $1.02 | N/A |
Stock Comparison
ZMSPF vs SMMNY Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, SMMNY has a market cap of 119.9B. Regarding current trading prices, ZMSPF is priced at $0.00, while SMMNY trades at $26.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas SMMNY's P/E ratio is 24.30. In terms of profitability, ZMSPF's ROE is +0.82%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, ZMSPF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check SMMNY's competition here
ZMSPF vs SEMHF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, SEMHF has a market cap of 61.7B. Regarding current trading prices, ZMSPF is priced at $0.00, while SEMHF trades at $54.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas SEMHF's P/E ratio is 25.13. In terms of profitability, ZMSPF's ROE is +0.82%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, ZMSPF is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check SEMHF's competition here
ZMSPF vs RYLPF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, RYLPF has a market cap of 25.2B. Regarding current trading prices, ZMSPF is priced at $0.00, while RYLPF trades at $26.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas RYLPF's P/E ratio is 147.19. In terms of profitability, ZMSPF's ROE is +0.82%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, ZMSPF is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check RYLPF's competition here
ZMSPF vs SONVF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, SONVF has a market cap of 17.8B. Regarding current trading prices, ZMSPF is priced at $0.00, while SONVF trades at $298.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas SONVF's P/E ratio is 26.80. In terms of profitability, ZMSPF's ROE is +0.82%, compared to SONVF's ROE of +0.22%. Regarding short-term risk, ZMSPF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check SONVF's competition here
ZMSPF vs SONVY Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, SONVY has a market cap of 16.4B. Regarding current trading prices, ZMSPF is priced at $0.00, while SONVY trades at $54.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas SONVY's P/E ratio is 24.77. In terms of profitability, ZMSPF's ROE is +0.82%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, ZMSPF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check SONVY's competition here
ZMSPF vs CHEOY Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, CHEOY has a market cap of 13.2B. Regarding current trading prices, ZMSPF is priced at $0.00, while CHEOY trades at $101.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas CHEOY's P/E ratio is 55.02. In terms of profitability, ZMSPF's ROE is +0.82%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, ZMSPF is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check CHEOY's competition here
ZMSPF vs SNNUF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, SNNUF has a market cap of 13.1B. Regarding current trading prices, ZMSPF is priced at $0.00, while SNNUF trades at $15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas SNNUF's P/E ratio is 31.91. In terms of profitability, ZMSPF's ROE is +0.82%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, ZMSPF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check SNNUF's competition here
ZMSPF vs CHEOF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, CHEOF has a market cap of 11.9B. Regarding current trading prices, ZMSPF is priced at $0.00, while CHEOF trades at $182.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas CHEOF's P/E ratio is 49.86. In terms of profitability, ZMSPF's ROE is +0.82%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, ZMSPF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check CHEOF's competition here
ZMSPF vs WILYY Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, WILYY has a market cap of 9.2B. Regarding current trading prices, ZMSPF is priced at $0.00, while WILYY trades at $21.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas WILYY's P/E ratio is 21.09. In terms of profitability, ZMSPF's ROE is +0.82%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, ZMSPF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check WILYY's competition here
ZMSPF vs WILLF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, WILLF has a market cap of 7.9B. Regarding current trading prices, ZMSPF is priced at $0.00, while WILLF trades at $38.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas WILLF's P/E ratio is 18.41. In terms of profitability, ZMSPF's ROE is +0.82%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, ZMSPF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check WILLF's competition here
ZMSPF vs GNGBY Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, GNGBY has a market cap of 5.3B. Regarding current trading prices, ZMSPF is priced at $0.00, while GNGBY trades at $19.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas GNGBY's P/E ratio is 35.11. In terms of profitability, ZMSPF's ROE is +0.82%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, ZMSPF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check GNGBY's competition here
ZMSPF vs GNGBF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, GNGBF has a market cap of 5.1B. Regarding current trading prices, ZMSPF is priced at $0.00, while GNGBF trades at $20.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas GNGBF's P/E ratio is 36.11. In terms of profitability, ZMSPF's ROE is +0.82%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, ZMSPF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check GNGBF's competition here
ZMSPF vs AMBBY Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, AMBBY has a market cap of 3.7B. Regarding current trading prices, ZMSPF is priced at $0.00, while AMBBY trades at $15.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas AMBBY's P/E ratio is 72.62. In terms of profitability, ZMSPF's ROE is +0.82%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, ZMSPF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check AMBBY's competition here
ZMSPF vs AMBFF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, AMBFF has a market cap of 3.7B. Regarding current trading prices, ZMSPF is priced at $0.00, while AMBFF trades at $14.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas AMBFF's P/E ratio is 66.90. In terms of profitability, ZMSPF's ROE is +0.82%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, ZMSPF is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check AMBFF's competition here
ZMSPF vs NHNKY Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, NHNKY has a market cap of 3.7B. Regarding current trading prices, ZMSPF is priced at $0.00, while NHNKY trades at $11.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas NHNKY's P/E ratio is 19.63. In terms of profitability, ZMSPF's ROE is +0.82%, compared to NHNKY's ROE of +0.08%. Regarding short-term risk, ZMSPF is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check NHNKY's competition here
ZMSPF vs MCRPF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, MCRPF has a market cap of 3.3B. Regarding current trading prices, ZMSPF is priced at $0.00, while MCRPF trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas MCRPF's P/E ratio is -14.92. In terms of profitability, ZMSPF's ROE is +0.82%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, ZMSPF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check MCRPF's competition here
ZMSPF vs NHNKF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, ZMSPF is priced at $0.00, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, ZMSPF's ROE is +0.82%, compared to NHNKF's ROE of +0.08%. Regarding short-term risk, ZMSPF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check NHNKF's competition here
ZMSPF vs OSSFF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, OSSFF has a market cap of 2.2B. Regarding current trading prices, ZMSPF is priced at $0.00, while OSSFF trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas OSSFF's P/E ratio is 30.00. In terms of profitability, ZMSPF's ROE is +0.82%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, ZMSPF is more volatile compared to OSSFF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check OSSFF's competition here
ZMSPF vs GNNDY Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, GNNDY has a market cap of 2.1B. Regarding current trading prices, ZMSPF is priced at $0.00, while GNNDY trades at $42.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas GNNDY's P/E ratio is 16.87. In terms of profitability, ZMSPF's ROE is +0.82%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, ZMSPF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check GNNDY's competition here
ZMSPF vs STSEY Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, ZMSPF is priced at $0.00, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas STSEY's P/E ratio is 39.41. In terms of profitability, ZMSPF's ROE is +0.82%, compared to STSEY's ROE of +0.07%. Regarding short-term risk, ZMSPF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check STSEY's competition here
ZMSPF vs VTRLY Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, VTRLY has a market cap of 2B. Regarding current trading prices, ZMSPF is priced at $0.00, while VTRLY trades at $14.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas VTRLY's P/E ratio is 43.82. In terms of profitability, ZMSPF's ROE is +0.82%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, ZMSPF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check VTRLY's competition here
ZMSPF vs GGNDF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, GGNDF has a market cap of 1.8B. Regarding current trading prices, ZMSPF is priced at $0.00, while GGNDF trades at $12.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas GGNDF's P/E ratio is 14.60. In terms of profitability, ZMSPF's ROE is +0.82%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, ZMSPF is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check GGNDF's competition here
ZMSPF vs DWRKF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, ZMSPF is priced at $0.00, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, ZMSPF's ROE is +0.82%, compared to DWRKF's ROE of N/A. Regarding short-term risk, ZMSPF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check DWRKF's competition here
ZMSPF vs OSSUY Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, ZMSPF is priced at $0.00, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, ZMSPF's ROE is +0.82%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, ZMSPF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check OSSUY's competition here
ZMSPF vs MEDGF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, ZMSPF is priced at $0.00, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, ZMSPF's ROE is +0.82%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, ZMSPF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check MEDGF's competition here
ZMSPF vs DRWKF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, DRWKF has a market cap of 1.4B. Regarding current trading prices, ZMSPF is priced at $0.00, while DRWKF trades at $70.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas DRWKF's P/E ratio is 9.78. In terms of profitability, ZMSPF's ROE is +0.82%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, ZMSPF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check DRWKF's competition here
ZMSPF vs MDRSF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, MDRSF has a market cap of 1.3B. Regarding current trading prices, ZMSPF is priced at $0.00, while MDRSF trades at $102.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas MDRSF's P/E ratio is 300.03. In terms of profitability, ZMSPF's ROE is +0.82%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, ZMSPF is more volatile compared to MDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check MDRSF's competition here
ZMSPF vs IMEXF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, IMEXF has a market cap of 1.2B. Regarding current trading prices, ZMSPF is priced at $0.00, while IMEXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas IMEXF's P/E ratio is -0.17. In terms of profitability, ZMSPF's ROE is +0.82%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, ZMSPF is more volatile compared to IMEXF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check IMEXF's competition here
ZMSPF vs DGWPF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, DGWPF has a market cap of 1.1B. Regarding current trading prices, ZMSPF is priced at $0.00, while DGWPF trades at $55.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas DGWPF's P/E ratio is 7.98. In terms of profitability, ZMSPF's ROE is +0.82%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, ZMSPF is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check DGWPF's competition here
ZMSPF vs ELEAF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, ELEAF has a market cap of 1B. Regarding current trading prices, ZMSPF is priced at $0.00, while ELEAF trades at $12.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas ELEAF's P/E ratio is 14.23. In terms of profitability, ZMSPF's ROE is +0.82%, compared to ELEAF's ROE of +0.15%. Regarding short-term risk, ZMSPF is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check ELEAF's competition here
ZMSPF vs LFTSF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, LFTSF has a market cap of 858.1M. Regarding current trading prices, ZMSPF is priced at $0.00, while LFTSF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas LFTSF's P/E ratio is 19.50. In terms of profitability, ZMSPF's ROE is +0.82%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, ZMSPF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check LFTSF's competition here
ZMSPF vs XVIPF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, XVIPF has a market cap of 646.9M. Regarding current trading prices, ZMSPF is priced at $0.00, while XVIPF trades at $20.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas XVIPF's P/E ratio is 57.04. In terms of profitability, ZMSPF's ROE is +0.82%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, ZMSPF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check XVIPF's competition here
ZMSPF vs DMTRF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, DMTRF has a market cap of 628.8M. Regarding current trading prices, ZMSPF is priced at $0.00, while DMTRF trades at $2.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas DMTRF's P/E ratio is -35.86. In terms of profitability, ZMSPF's ROE is +0.82%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, ZMSPF is more volatile compared to DMTRF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check DMTRF's competition here
ZMSPF vs CALZF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, CALZF has a market cap of 576M. Regarding current trading prices, ZMSPF is priced at $0.00, while CALZF trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas CALZF's P/E ratio is 83.37. In terms of profitability, ZMSPF's ROE is +0.82%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, ZMSPF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check CALZF's competition here
ZMSPF vs CLVSF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, CLVSF has a market cap of 556.5M. Regarding current trading prices, ZMSPF is priced at $0.00, while CLVSF trades at $23.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas CLVSF's P/E ratio is 38.25. In terms of profitability, ZMSPF's ROE is +0.82%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, ZMSPF is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check CLVSF's competition here
ZMSPF vs LBLTF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, LBLTF has a market cap of 496.1M. Regarding current trading prices, ZMSPF is priced at $0.00, while LBLTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas LBLTF's P/E ratio is -1.22. In terms of profitability, ZMSPF's ROE is +0.82%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, ZMSPF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for ZMSPF.Check LBLTF's competition here
ZMSPF vs AVMR Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, ZMSPF is priced at $0.00, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas AVMR's P/E ratio is -18.34. In terms of profitability, ZMSPF's ROE is +0.82%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, ZMSPF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check AVMR's competition here
ZMSPF vs IOBCF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, IOBCF has a market cap of 382M. Regarding current trading prices, ZMSPF is priced at $0.00, while IOBCF trades at $13.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas IOBCF's P/E ratio is 36.22. In terms of profitability, ZMSPF's ROE is +0.82%, compared to IOBCF's ROE of +0.09%. Regarding short-term risk, ZMSPF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check IOBCF's competition here
ZMSPF vs HYBT Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, ZMSPF is priced at $0.00, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas HYBT's P/E ratio is N/A. In terms of profitability, ZMSPF's ROE is +0.82%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, ZMSPF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check HYBT's competition here
ZMSPF vs LLBO Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, LLBO has a market cap of 347.9M. Regarding current trading prices, ZMSPF is priced at $0.00, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas LLBO's P/E ratio is N/A. In terms of profitability, ZMSPF's ROE is +0.82%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, ZMSPF is more volatile compared to LLBO. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check LLBO's competition here
ZMSPF vs EAPIF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, EAPIF has a market cap of 347.5M. Regarding current trading prices, ZMSPF is priced at $0.00, while EAPIF trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas EAPIF's P/E ratio is -2.31. In terms of profitability, ZMSPF's ROE is +0.82%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, ZMSPF is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check EAPIF's competition here
ZMSPF vs CSSPF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, CSSPF has a market cap of 271.3M. Regarding current trading prices, ZMSPF is priced at $0.00, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, ZMSPF's ROE is +0.82%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, ZMSPF is more volatile compared to CSSPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check CSSPF's competition here
ZMSPF vs CLLKF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, CLLKF has a market cap of 260.1M. Regarding current trading prices, ZMSPF is priced at $0.00, while CLLKF trades at $3.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas CLLKF's P/E ratio is -8.37. In terms of profitability, ZMSPF's ROE is +0.82%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, ZMSPF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check CLLKF's competition here
ZMSPF vs CYBQY Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, CYBQY has a market cap of 259M. Regarding current trading prices, ZMSPF is priced at $0.00, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas CYBQY's P/E ratio is -61.00. In terms of profitability, ZMSPF's ROE is +0.82%, compared to CYBQY's ROE of -0.01%. Regarding short-term risk, ZMSPF is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check CYBQY's competition here
ZMSPF vs HTLZF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, ZMSPF is priced at $0.00, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, ZMSPF's ROE is +0.82%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, ZMSPF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check HTLZF's competition here
ZMSPF vs CYBQF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, CYBQF has a market cap of 173.5M. Regarding current trading prices, ZMSPF is priced at $0.00, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas CYBQF's P/E ratio is -65.00. In terms of profitability, ZMSPF's ROE is +0.82%, compared to CYBQF's ROE of -0.01%. Regarding short-term risk, ZMSPF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check CYBQF's competition here
ZMSPF vs BCCOY Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, BCCOY has a market cap of 172.6M. Regarding current trading prices, ZMSPF is priced at $0.00, while BCCOY trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas BCCOY's P/E ratio is -5.68. In terms of profitability, ZMSPF's ROE is +0.82%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, ZMSPF is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check BCCOY's competition here
ZMSPF vs BRNHF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, BRNHF has a market cap of 162.1M. Regarding current trading prices, ZMSPF is priced at $0.00, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, ZMSPF's ROE is +0.82%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, ZMSPF is more volatile compared to BRNHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check BRNHF's competition here
ZMSPF vs EKDHF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, EKDHF has a market cap of 161.7M. Regarding current trading prices, ZMSPF is priced at $0.00, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, ZMSPF's ROE is +0.82%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, ZMSPF is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check EKDHF's competition here
ZMSPF vs PXMBF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, PXMBF has a market cap of 153.3M. Regarding current trading prices, ZMSPF is priced at $0.00, while PXMBF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas PXMBF's P/E ratio is 23.33. In terms of profitability, ZMSPF's ROE is +0.82%, compared to PXMBF's ROE of +0.12%. Regarding short-term risk, ZMSPF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check PXMBF's competition here
ZMSPF vs AVHHL Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, AVHHL has a market cap of 133.3M. Regarding current trading prices, ZMSPF is priced at $0.00, while AVHHL trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas AVHHL's P/E ratio is -2.20. In terms of profitability, ZMSPF's ROE is +0.82%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, ZMSPF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check AVHHL's competition here
ZMSPF vs BRSYF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, BRSYF has a market cap of 128.5M. Regarding current trading prices, ZMSPF is priced at $0.00, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, ZMSPF's ROE is +0.82%, compared to BRSYF's ROE of +0.07%. Regarding short-term risk, ZMSPF is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check BRSYF's competition here
ZMSPF vs VMTHF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, VMTHF has a market cap of 125.7M. Regarding current trading prices, ZMSPF is priced at $0.00, while VMTHF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas VMTHF's P/E ratio is -1.25. In terms of profitability, ZMSPF's ROE is +0.82%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, ZMSPF is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check VMTHF's competition here
ZMSPF vs AMEUF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, ZMSPF is priced at $0.00, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, ZMSPF's ROE is +0.82%, compared to AMEUF's ROE of -5.13%. Regarding short-term risk, ZMSPF is more volatile compared to AMEUF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check AMEUF's competition here
ZMSPF vs SNZZF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, SNZZF has a market cap of 108.5M. Regarding current trading prices, ZMSPF is priced at $0.00, while SNZZF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas SNZZF's P/E ratio is -6.90. In terms of profitability, ZMSPF's ROE is +0.82%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, ZMSPF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check SNZZF's competition here
ZMSPF vs FDMDF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, FDMDF has a market cap of 106.1M. Regarding current trading prices, ZMSPF is priced at $0.00, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, ZMSPF's ROE is +0.82%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, ZMSPF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check FDMDF's competition here
ZMSPF vs JMDMF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, JMDMF has a market cap of 104.4M. Regarding current trading prices, ZMSPF is priced at $0.00, while JMDMF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas JMDMF's P/E ratio is -27.83. In terms of profitability, ZMSPF's ROE is +0.82%, compared to JMDMF's ROE of N/A. Regarding short-term risk, ZMSPF is more volatile compared to JMDMF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check JMDMF's competition here
ZMSPF vs IMPZY Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, IMPZY has a market cap of 100M. Regarding current trading prices, ZMSPF is priced at $0.00, while IMPZY trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas IMPZY's P/E ratio is -0.80. In terms of profitability, ZMSPF's ROE is +0.82%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, ZMSPF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check IMPZY's competition here
ZMSPF vs SOMNF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, SOMNF has a market cap of 92.1M. Regarding current trading prices, ZMSPF is priced at $0.00, while SOMNF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas SOMNF's P/E ratio is -14.20. In terms of profitability, ZMSPF's ROE is +0.82%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, ZMSPF is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check SOMNF's competition here
ZMSPF vs RSHUF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, ZMSPF is priced at $0.00, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, ZMSPF's ROE is +0.82%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, ZMSPF is more volatile compared to RSHUF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check RSHUF's competition here
ZMSPF vs CKMTF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, ZMSPF is priced at $0.00, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, ZMSPF's ROE is +0.82%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, ZMSPF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check CKMTF's competition here
ZMSPF vs IPDQF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, IPDQF has a market cap of 63.1M. Regarding current trading prices, ZMSPF is priced at $0.00, while IPDQF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas IPDQF's P/E ratio is -3.11. In terms of profitability, ZMSPF's ROE is +0.82%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, ZMSPF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check IPDQF's competition here
ZMSPF vs RDGL Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, RDGL has a market cap of 50.5M. Regarding current trading prices, ZMSPF is priced at $0.00, while RDGL trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas RDGL's P/E ratio is -11.14. In terms of profitability, ZMSPF's ROE is +0.82%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, ZMSPF is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check RDGL's competition here
ZMSPF vs BLOZF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, BLOZF has a market cap of 47.7M. Regarding current trading prices, ZMSPF is priced at $0.00, while BLOZF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas BLOZF's P/E ratio is -20.72. In terms of profitability, ZMSPF's ROE is +0.82%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, ZMSPF is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check BLOZF's competition here
ZMSPF vs CRRVF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, CRRVF has a market cap of 46.3M. Regarding current trading prices, ZMSPF is priced at $0.00, while CRRVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas CRRVF's P/E ratio is -0.01. In terms of profitability, ZMSPF's ROE is +0.82%, compared to CRRVF's ROE of +0.00%. Regarding short-term risk, ZMSPF is less volatile compared to CRRVF. This indicates potentially lower risk in terms of short-term price fluctuations for ZMSPF.Check CRRVF's competition here
ZMSPF vs TLTFF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, TLTFF has a market cap of 40.1M. Regarding current trading prices, ZMSPF is priced at $0.00, while TLTFF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas TLTFF's P/E ratio is -16.00. In terms of profitability, ZMSPF's ROE is +0.82%, compared to TLTFF's ROE of -2.57%. Regarding short-term risk, ZMSPF is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check TLTFF's competition here
ZMSPF vs NVYTF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, NVYTF has a market cap of 38.1M. Regarding current trading prices, ZMSPF is priced at $0.00, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas NVYTF's P/E ratio is -0.74. In terms of profitability, ZMSPF's ROE is +0.82%, compared to NVYTF's ROE of +0.00%. Regarding short-term risk, ZMSPF is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check NVYTF's competition here
ZMSPF vs ELXMF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, ELXMF has a market cap of 28.4M. Regarding current trading prices, ZMSPF is priced at $0.00, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, ZMSPF's ROE is +0.82%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, ZMSPF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check ELXMF's competition here
ZMSPF vs MKEAF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, ZMSPF is priced at $0.00, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, ZMSPF's ROE is +0.82%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, ZMSPF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check MKEAF's competition here
ZMSPF vs POSC Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, POSC has a market cap of 25.6M. Regarding current trading prices, ZMSPF is priced at $0.00, while POSC trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas POSC's P/E ratio is 0.38. In terms of profitability, ZMSPF's ROE is +0.82%, compared to POSC's ROE of +9.25%. Regarding short-term risk, ZMSPF is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check POSC's competition here
ZMSPF vs PLLWF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, PLLWF has a market cap of 24.1M. Regarding current trading prices, ZMSPF is priced at $0.00, while PLLWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas PLLWF's P/E ratio is -2.00. In terms of profitability, ZMSPF's ROE is +0.82%, compared to PLLWF's ROE of -0.61%. Regarding short-term risk, ZMSPF is more volatile compared to PLLWF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check PLLWF's competition here
ZMSPF vs KBBTF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, ZMSPF is priced at $0.00, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, ZMSPF's ROE is +0.82%, compared to KBBTF's ROE of N/A. Regarding short-term risk, ZMSPF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check KBBTF's competition here
ZMSPF vs EMITF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, EMITF has a market cap of 23.2M. Regarding current trading prices, ZMSPF is priced at $0.00, while EMITF trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas EMITF's P/E ratio is -11.67. In terms of profitability, ZMSPF's ROE is +0.82%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, ZMSPF is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check EMITF's competition here
ZMSPF vs GTHP Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, GTHP has a market cap of 21.7M. Regarding current trading prices, ZMSPF is priced at $0.00, while GTHP trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas GTHP's P/E ratio is -5.50. In terms of profitability, ZMSPF's ROE is +0.82%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, ZMSPF is more volatile compared to GTHP. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check GTHP's competition here
ZMSPF vs PYNKF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, PYNKF has a market cap of 18.8M. Regarding current trading prices, ZMSPF is priced at $0.00, while PYNKF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas PYNKF's P/E ratio is -0.90. In terms of profitability, ZMSPF's ROE is +0.82%, compared to PYNKF's ROE of -1.58%. Regarding short-term risk, ZMSPF is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check PYNKF's competition here
ZMSPF vs ASAPF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, ASAPF has a market cap of 18.8M. Regarding current trading prices, ZMSPF is priced at $0.00, while ASAPF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas ASAPF's P/E ratio is -24.03. In terms of profitability, ZMSPF's ROE is +0.82%, compared to ASAPF's ROE of -0.23%. Regarding short-term risk, ZMSPF is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check ASAPF's competition here
ZMSPF vs DIZTF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, ZMSPF is priced at $0.00, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, ZMSPF's ROE is +0.82%, compared to DIZTF's ROE of -2.22%. Regarding short-term risk, ZMSPF is more volatile compared to DIZTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check DIZTF's competition here
ZMSPF vs VPTDF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, VPTDF has a market cap of 16.9M. Regarding current trading prices, ZMSPF is priced at $0.00, while VPTDF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas VPTDF's P/E ratio is -5.05. In terms of profitability, ZMSPF's ROE is +0.82%, compared to VPTDF's ROE of +1.70%. Regarding short-term risk, ZMSPF is more volatile compared to VPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check VPTDF's competition here
ZMSPF vs MDXHF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, MDXHF has a market cap of 15.3M. Regarding current trading prices, ZMSPF is priced at $0.00, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, ZMSPF's ROE is +0.82%, compared to MDXHF's ROE of +0.49%. Regarding short-term risk, ZMSPF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check MDXHF's competition here
ZMSPF vs TMDIF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, ZMSPF is priced at $0.00, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, ZMSPF's ROE is +0.82%, compared to TMDIF's ROE of -1.38%. Regarding short-term risk, ZMSPF is more volatile compared to TMDIF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check TMDIF's competition here
ZMSPF vs ATBPF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, ZMSPF is priced at $0.00, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, ZMSPF's ROE is +0.82%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, ZMSPF is more volatile compared to ATBPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check ATBPF's competition here
ZMSPF vs LXXGF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, ZMSPF is priced at $0.00, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, ZMSPF's ROE is +0.82%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, ZMSPF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check LXXGF's competition here
ZMSPF vs NGMDF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, NGMDF has a market cap of 10.6M. Regarding current trading prices, ZMSPF is priced at $0.00, while NGMDF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas NGMDF's P/E ratio is -4.67. In terms of profitability, ZMSPF's ROE is +0.82%, compared to NGMDF's ROE of +0.36%. Regarding short-term risk, ZMSPF is more volatile compared to NGMDF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check NGMDF's competition here
ZMSPF vs RMSL Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, RMSL has a market cap of 10.1M. Regarding current trading prices, ZMSPF is priced at $0.00, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas RMSL's P/E ratio is 0.66. In terms of profitability, ZMSPF's ROE is +0.82%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, ZMSPF is more volatile compared to RMSL. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check RMSL's competition here
ZMSPF vs ALRTF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, ALRTF has a market cap of 7.9M. Regarding current trading prices, ZMSPF is priced at $0.00, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas ALRTF's P/E ratio is -0.41. In terms of profitability, ZMSPF's ROE is +0.82%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, ZMSPF is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check ALRTF's competition here
ZMSPF vs FZMD Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, FZMD has a market cap of 7.4M. Regarding current trading prices, ZMSPF is priced at $0.00, while FZMD trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas FZMD's P/E ratio is 2.00. In terms of profitability, ZMSPF's ROE is +0.82%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, ZMSPF is more volatile compared to FZMD. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check FZMD's competition here
ZMSPF vs DTXMF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, DTXMF has a market cap of 5.7M. Regarding current trading prices, ZMSPF is priced at $0.00, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, ZMSPF's ROE is +0.82%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, ZMSPF is more volatile compared to DTXMF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check DTXMF's competition here
ZMSPF vs QLIS Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, ZMSPF is priced at $0.00, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas QLIS's P/E ratio is 2.22. In terms of profitability, ZMSPF's ROE is +0.82%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, ZMSPF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check QLIS's competition here
ZMSPF vs RHNMF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, ZMSPF is priced at $0.00, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, ZMSPF's ROE is +0.82%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, ZMSPF is more volatile compared to RHNMF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check RHNMF's competition here
ZMSPF vs VYCO Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, VYCO has a market cap of 4.3M. Regarding current trading prices, ZMSPF is priced at $0.00, while VYCO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas VYCO's P/E ratio is -13.00. In terms of profitability, ZMSPF's ROE is +0.82%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, ZMSPF is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check VYCO's competition here
ZMSPF vs NUMD Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, NUMD has a market cap of 4.2M. Regarding current trading prices, ZMSPF is priced at $0.00, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas NUMD's P/E ratio is 5.00. In terms of profitability, ZMSPF's ROE is +0.82%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, ZMSPF is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check NUMD's competition here
ZMSPF vs ADMT Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, ADMT has a market cap of 3.9M. Regarding current trading prices, ZMSPF is priced at $0.00, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas ADMT's P/E ratio is -5.79. In terms of profitability, ZMSPF's ROE is +0.82%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, ZMSPF is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check ADMT's competition here
ZMSPF vs VANIW Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, ZMSPF is priced at $0.00, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas VANIW's P/E ratio is N/A. In terms of profitability, ZMSPF's ROE is +0.82%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, ZMSPF is more volatile compared to VANIW. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check VANIW's competition here
ZMSPF vs PMEDF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, PMEDF has a market cap of 3.3M. Regarding current trading prices, ZMSPF is priced at $0.00, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas PMEDF's P/E ratio is -1.70. In terms of profitability, ZMSPF's ROE is +0.82%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, ZMSPF is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check PMEDF's competition here
ZMSPF vs TBRIF Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, TBRIF has a market cap of 3.2M. Regarding current trading prices, ZMSPF is priced at $0.00, while TBRIF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas TBRIF's P/E ratio is -0.83. In terms of profitability, ZMSPF's ROE is +0.82%, compared to TBRIF's ROE of -2.28%. Regarding short-term risk, ZMSPF is more volatile compared to TBRIF. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check TBRIF's competition here
ZMSPF vs ODYY Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, ODYY has a market cap of 2.2M. Regarding current trading prices, ZMSPF is priced at $0.00, while ODYY trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas ODYY's P/E ratio is -0.15. In terms of profitability, ZMSPF's ROE is +0.82%, compared to ODYY's ROE of +2.30%. Regarding short-term risk, ZMSPF is more volatile compared to ODYY. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check ODYY's competition here
ZMSPF vs UAHC Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, UAHC has a market cap of 2.1M. Regarding current trading prices, ZMSPF is priced at $0.00, while UAHC trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas UAHC's P/E ratio is 0.98. In terms of profitability, ZMSPF's ROE is +0.82%, compared to UAHC's ROE of +0.07%. Regarding short-term risk, ZMSPF is more volatile compared to UAHC. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check UAHC's competition here
ZMSPF vs ESMC Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, ESMC has a market cap of 2M. Regarding current trading prices, ZMSPF is priced at $0.00, while ESMC trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas ESMC's P/E ratio is 5.40. In terms of profitability, ZMSPF's ROE is +0.82%, compared to ESMC's ROE of +0.00%. Regarding short-term risk, ZMSPF is more volatile compared to ESMC. This indicates potentially higher risk in terms of short-term price fluctuations for ZMSPF.Check ESMC's competition here
ZMSPF vs MSIU Comparison August 2025
ZMSPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZMSPF stands at 12.3M. In comparison, MSIU has a market cap of 1.9M. Regarding current trading prices, ZMSPF is priced at $0.00, while MSIU trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZMSPF currently has a P/E ratio of N/A, whereas MSIU's P/E ratio is -2.19. In terms of profitability, ZMSPF's ROE is +0.82%, compared to MSIU's ROE of -3.07%. Regarding short-term risk, ZMSPF is less volatile compared to MSIU. This indicates potentially lower risk in terms of short-term price fluctuations for ZMSPF.Check MSIU's competition here